References
- Bian XW, Shi JQ, Liu FX. Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors. Anal Quant Cytol Histol 2000;22:429–37.
- Ohgaki H, Kleihues P. Genetic profile of astrocytic and oligodendroglial gliomas. Brain Tumor Pathol 2011;28: 177–83.
- Brat DJ, Kaur B, Van Meir EG. Genetic modulation of hypoxia induced gene expression and angiogenesis: relevance to brain tumors. Front Biosci 2003;8:100–16.
- Haque A, Banik NL, Ray SK. Molecular alterations in glioblastoma: potential targets for immunotherapy. Prog Mol Biol Transl Sci 2011;98:187–234.
- Hwang SL, Hong YR, Chai CY, Prognostic evaluation in supratentorial astrocytic tumors using p53, epidermal growth factor receptor, c-erbB-2 immunostaining. Kaohsiung J Med Sci 1998;14:607–15.
- Alahmadi H, Croul SE. Pathology and genetics of meningiomas. Semin Diagn Pathol 2011;28:314–24.
- Jensen RL. Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 2009;92:317–35.
- Chan DA, Sutphin PD, Denko NC, Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J Biol Chem 2002;277:40112–17.
- Hendriksen EM, Span PN, Schuuring J, HIF-1alpha-dependent gene expression program during the nucleic acid-triggered antiviral innate immune responses. Microvasc Res 2009;77:96–103.
- Hong SW, Yoo JW, Kang HS, HIF-1alpha-dependent gene expression program during the nucleic acid-triggered antiviral innate immune responses. Mol Cells 2009; 27:243–50.
- Søndergaard KL, Hilton DA, Penney M, Expression of hypoxia-inducible factor 1alpha in tumours of patients with glioblastoma. Neuropathol Appl Neurobiol 2002;28: 210–17.
- Wolf A, Agnihotri S, Guha A. Targeting metabolic remodeling in glioblastoma multiforme. Oncotarget 2010;1: 552–62.
- Zundel W, Schindler C, Haas-Kogan D, Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 2000;14:391–6.
- Preusser M, Hassler M, Birner P, Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches. Clin Neuropathol 2012;31:352–60.
- Brat DJ, Mapstone TB. Malignant glioma physiology: cellular response to hypoxia and its role in tumor progression. Ann Intern Med 2003;138:659–68.
- Kaynar MY, Sanus GZ, Hnimoglu H, Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model. J Clin Neurosci 2008; 15:1036–42.
- Mayer A, Schneider F, Vaupel P, Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma. Int J Oncol 2012;16:1260–70.
- Jensen RL, Soleau S, Bhayani MK, Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas. J Neurosurg 2002;97:658–67.
- Jensen R, Lee J. Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation. Neurosurgery 2012;71:146–56.